It is currently Wed Jul 30, 2014 12:36 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

MS drug Tysabri should return to market: Panel Decision

Results from the panel meeting yesterday.

Original link:


GAITHERSBURG, Maryland (Reuters) - Biogen Idec's (Nasdaq:BIIB - news) multiple sclerosis drug Tysabri should return to the market with safeguards to closely monitor patients for a potentially fatal complication, a U.S. advisory panel unanimously ruled on Wednesday.

Biogen and marketing partner Elan Corp. (NYSE:ELN - news) (ELN.I) voluntarily suspended sales in February 2005 after three patients developed a brain ...

BioMS SPMS drug

The following is an update from BioMS on their SPMS drug that they have been working on for over 5 years now. It's one of the few drugs for SPMS that anyone has spent much time on.



BioMS Medical's MBP8298 shows five-year delay of disease progression in patients with multiple sclerosis

-Results to be presented at the American Academy of Neurology April 4,

Toronto Stock Exchange Symbol: MS

EDMONTON, March 7 - ...
Read more : BioMS SPMS drug | Views : 1246 | Replies : 6 | Forum : General Discussion

Axonal degeneration

A techy article but it mentions neuro-protection.

Dignan, with his Chemistry PhD, has kindly offered to translate the article into layman's terms.

Read more : Axonal degeneration | Views : 1040 | Replies : 1 | Forum : General Discussion

The plaque and its pathogenesis

This looked a good read but you have to purchase the full article.

Given that most Americans are millionaires it would be a nice gesture to your British cousins (given all we do for you) to purchase the article and tell us what's in it.

Read more : The plaque and its pathogenesis | Views : 998 | Replies : 1 | Forum : General Discussion


I'm sure someone had asked about prognosis before. This piece of research looks at the prognosis for those with early on-set MS.

Read more : Prognosis | Views : 928 | Replies : 0 | Forum : General Discussion

Neurocrine APL


If this was on the list you need to erase it.

Read more : Neurocrine APL | Views : 1286 | Replies : 1 | Forum : Drug Pipeline

Question about interactions with Rebif

I planned to ask my neuro today if any of the supplements I'm taking might interact with Rebif since I am going to be starting it soon. Unfortunately I only got the nurse and she couldn't get me off the phone quick enough. Right now I am taking Omega 3, Lecithin and a multivitamin plus Allegra for my sinus and allergy problems. Were you told of any supplements or other medications to avoid when taking ...
Read more : Question about interactions with Rebif | Views : 3022 | Replies : 4 | Forum : Rebif

Better/Easier flagyl taste

Flagyl tastes better... No, really, it's true! I have found a way to take flagyl and not taste it and it will probably make you happier every time you do! I take the flagyl tablet out, coat it with jam or jelly and toss it in my mouth, quickly followed by a water chaser. You'll NEVER taste a thing, except maybe a fleeting taste of the jam. DO NOT LICK YOUR FINGERS before washing them ...
Read more : Better/Easier flagyl taste | Views : 2360 | Replies : 0 | Forum : Antibiotics

How many of you have been referred to a neuropsychiatrist?

:lol: Following a referral to a neuropsychiatrist, I have now been told to start Lithium. Does anyone know anything about lithium?

Sue !!
Read more : How many of you have been referred to a neuropsychiatrist? | Views : 1204 | Replies : 3 | Forum : General Discussion

MBP8298 update

This sounds promising, although they don't provide much information here...

BioMS Medical's MBP8298 Shows Five-year Delay of Disease Progression in Patients with Multiple Sclerosis

March 7, 2006- BioMS Medical today announced that its proprietary drug candidate MBP8298 delayed disease progression for five years in progressive MS patients with HLA-DR2 or HLA-DR4 immune response genes.

Treatment and follow-up of patients from a phase II clinical study demonstrated that patients in this DR2 and DR4 responder group, ...
Read more : MBP8298 update | Views : 1230 | Replies : 1 | Forum : Drug Pipeline


Login  •  Register


Total posts 218763 • Total topics 22548 • Total members 14193